Dr. Kelly Broster, a former cancer research scientist, is now focused on biopharmaceutical and pharmaceutical applications with a focus on customer needs in the Chromatography and Mass Spectrometry Division at Thermo Fisher Scientific. Kelly has enjoyed spending the majority of her career, thus far, utilizing the power of mass spectrometry to help improve our understanding of human disease. She has a strong background in biomedical sciences, including a Masters Degree in Biomedical Science, a PhD in Cancer Proteomics and a post doctoral position in Systems Oncology. From her previous role at Cancer Research UK, she has developed a keen understanding of analytical workflows for research scientists in the major therapeutic research area of oncology. Kelly maintains a keen interest in biotherapeutic research and drug development and is motivated by the ability to facilitate customer success through Thermo Fisher Scientific innovative technology and powerful workflow solutions.